Home › Cyclica And Dalton Announce Collaboration Agreement To Identify And Develop New Drug Candidates
 

Keywords :   


Cyclica And Dalton Announce Collaboration Agreement To Identify And Develop New Drug Candidates

2013-04-12 09:19:56| drugdiscoveryonline News Articles

Jason Mitakidis, President and CEO of Cyclica, Peter Pekos, President and CEO of Dalton Pharma Services and Dr. Judd Berman, Co-Founder of Dalton Medicinal Chemistry today announced a collaboration for the joint identification and development of a number of new drug candidates

Tags: agreement develop drug identify

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »